Literature DB >> 8856655

PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration.

H Nagasawa1, H Tanji, H Nomura, H Saito, Y Itoyama, I Kimura, S Tuji, T Fujiwara, R Iwata, M Itoh, T Ido.   

Abstract

We measured cerebral glucose utilization and fluorodopa metabolism in the brain of patients with corticobasal degeneration using position emission tomography. The clinical pictures are distinctive, comprising features referable to both cerebral cortical and basal ganglionic dysfunctions. Brain images of glucose metabolism can demonstrate specific abnormalities with a marked asymmetry in the parietal cortex (the primary motor and sensory cortex and the lateral parietal cortex), the thalamus, the caudate nucleus and the putamen of the dominantly affected hemisphere related to clinical symptoms in six patients. [18F]dopa uptake also reduced in an asymmetric pattern, both the caudate nucleus and the putamen in four patients. This unique combination study measuring both cerebral glucose utilization and fluorodopa metabolism in the nigrostriatal system can provide efficient information about the dysfunctions which are correlated with individual clinical symptoms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856655

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Neuropsychological and neuroimaging correlates in corticobasal degeneration.

Authors:  E Frasson; G Moretto; A Beltramello; N Smania; M Pampanin; C Stegagno; R Tanel; N Rizzuto
Journal:  Ital J Neurol Sci       Date:  1998-10

Review 2.  PET/CT in diagnosis of movement disorders.

Authors:  Valentina Berti; Alberto Pupi; Lisa Mosconi
Journal:  Ann N Y Acad Sci       Date:  2011-06       Impact factor: 5.691

Review 3.  Neurophysiology and neurochemistry of corticobasal syndrome.

Authors:  Aditya A Murgai; Mandar S Jog
Journal:  J Neurol       Date:  2018-01-06       Impact factor: 4.849

Review 4.  A model-based approach to understanding apraxia in Corticobasal Syndrome.

Authors:  Vessela Stamenova; Eric A Roy; Sandra E Black
Journal:  Neuropsychol Rev       Date:  2008-12-11       Impact factor: 7.444

5.  Dopamine Transporter SPECT Imaging in Corticobasal Syndrome.

Authors:  Roberto Cilia; Carlo Rossi; Daniela Frosini; Duccio Volterrani; Chiara Siri; Cristina Pagni; Riccardo Benti; Gianni Pezzoli; Ubaldo Bonuccelli; Angelo Antonini; Roberto Ceravolo
Journal:  PLoS One       Date:  2011-05-02       Impact factor: 3.240

Review 6.  Positron emission tomography in the differential diagnosis of parkinsonism.

Authors:  Juha O Rinne
Journal:  J Mov Disord       Date:  2009-10-30

Review 7.  A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism.

Authors:  Flavia Niccolini; Marios Politis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-07-28       Impact factor: 9.236

8.  Impact of TOF on Brain PET With Short-Lived 11C-Labeled Tracers Among Suspected Patients With AD/PD: Using Hybrid PET/MRI.

Authors:  D D N Wimalarathne; Weiwei Ruan; Xun Sun; Fang Liu; Yongkang Gai; Qingyao Liu; Fan Hu; Xiaoli Lan
Journal:  Front Med (Lausanne)       Date:  2022-03-02

Review 9.  Neurotransmitter deficits from frontotemporal lobar degeneration.

Authors:  Alexander G Murley; James B Rowe
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.